October 11, 2024- B. Braun Medical Inc. (B. Braun) announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the Introcan Safety® 2 Deep Access IV Catheter, the newest addition to the Introcan Safety 2 IV Catheter portfolio.
The Introcan Safety 2 Deep Access IV Catheter merges the trusted technologies of the original Introcan Safety 2 Multi-Access and Introcan Safety Deep Access Catheters, offering clinicians an advanced solution that combines the strengths of both devices. This innovative catheter provides fully automatic passive safety needlestick protection and multi-access blood control in longer lengths and is designed to access deeper veins in patients with difficult vascular access and to achieve longer dwell times.
The Introcan Safety Deep Access IV Catheter has been shown to significantly increase PIVC dwell times to approximately 5.7 days — compared to 3.8 days for standard long PIVCs — to help reduce PIVC restarts and help reduce escalation to more costly, invasive devices such as peripherally inserted central catheters (PICC).